HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchangers in the E6 and E7 proteins

Virology

Volumn 223, Issue 1, 1996, Pages 185-197

  Grassmann, K ^a   Wilczynski, S P ^b   Cook, N ^b   Rapp, B ^a   Iftner, T ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; OPEN READING FRAME; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; VIRUS ISOLATION; VIRUS STRAIN;

EID: 0030248067     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0467     Document Type: Article

References (73)

1. Aplan, P. D., Raimondi, S. C., and Kirsch, I. R. (1992). Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J. Exp. Med. 176, 1303-1310.
2. Band, V., Dalal, S., Delmolino, L., and Androphy, E. J. (1993). Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J. 12, 1847-1852.
3. Barbosa, M. S., Lowy, D. R., and Schiller, J. T. (1989). Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J. Virol. 63, 1404-1407.
4. Bercovich, J. A., Centeno, C. R., Aguilar, O. G., Grinstein, S., and Kahn, T. (1991). Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J. Gen. Virol. 72, 2569-2572.
5. Bernard, B. A., Bailly, C., Lenoir, M. C., Darmon, M., Thierry, F., and Yaniv, M. (1989). The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63, 4317-4324.
6. Boshart, M., and zur Hausen, H. (1986). Human papillomaviruses in Buschke-Lowenstein tumors: Physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J. Virol. 58, 963-966.
7. Boshart, M., Gissmann, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W., and zur Hausen, H. (1984). A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3, 1151-1157.
8. Chin, M. T., Broker, T. R., and Chow, L. T. (1989). Identification of a novel constitutive enhancer element and an associated binding protein: Implications for human papillomavirus type 11 enhancer regulation. J. Virol. 63, 2967-2976.
9. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
10. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Chong, T., Chan, W. K., and Bernard, H. U. (1990). Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: A model for the composition of genital papillomavirus enhancers. Nucleic Acids Res. 18, 465-470.
12. Cripe, T. P., Haugen, T. H.,Turk, J. P., Tabatabai, F., Schmid, P. G., Durst, M., Gissmann, L., Roman, A., and Turek, L. P. (1987). Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: Implications for cervical carcinogenesis. EMBO J. 6, 3745-3753.
13. Crook, T., Tidy, J. A., and Vousden, K. H. (1991). Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67, 547-556.
14. de Villiers, E. M., Gissmann, L., and zur Hausen, H. (1981). Molecular cloning of viral DNA from human genital warts. J. Virol. 40, 932-935.
15. de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., and Subramani, S. (1987). Firefly luciferase gene: Structure and expression in mammalian cells. Mol. Cell Biol. 7, 725-737.
16. Dong, X. P., Stubenrauch, F., Beyer Finkler, E., and Pfister, H. (1994). Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int. J. Cancer 58, 803-808.
17. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. (1989). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.
18. Farr, A., Wang, H., Kasher, M. S., and Roman, A. (1991). Relative enhancer activity and transforming potential of authentic human papillomavirus type 6 genomes from benign and malignant lesions. J. Gen. Virol. 72, 519-526.
19. Farr, A., Pattison, S., Youn, B.-S., and Roman, A. (1995). Detection of silencer activity in the long control regions of human papillomavirus type 6 isolated from both benign and malignant lesions. J. Gen. Virol. 76, 827-835.
20. Gage, J. R., Meyers, C., and Wettstein, F. O. (1990). The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J. Virol. 64, 723-730.
21. Gissmann, L., and zur Hausen, H. (1980). Partial characterization of viral DNA from human genital warts (condylomata acuminata). Int. J. Cancer 25, 605-609.
22. Gissmann, L., deVilliers, E. M., and zur Hausen, H. (1982). Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA .Int. J. Cancer 29, 143-146.
23. Gissmann, L., Wolnik, L., Ikenberg, H., Koldovsky, U., Schnurch, H. G., and zur Hausen, H. (1983). Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. USA 80, 560-563.
24. Gloss, B., Bernard, H. U., Seedorf, K., and Nock, G. (1987). The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6, 3735-3743.
25. Graham, F. L., and van der Eb, A. J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
26. Grassmann, K., Rapp, B., Maschek, H., Petry, K. U., and Iftner, T. (1996). Identification of a differentiation-inducible promoter in the E7 ORF of human papillomavirus type 16 (HPV16) in raft cultures of a new cell line containing high copy numbers of episomal HPV16 DNA. J. Virol. 70, 2339-2349.
27. Heck, D. V., Yee, C. L., Howley, P. M., and Munger, K. (1992). Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89, 4442-4446.
28. Hirochika, H., Hirochika, R., Broker, T. R., and Chow, L. T. (1988). Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev. 2, 54-67. [Published erratum appears in Genes Dev., 1988, 2(4), 490]
29. Hofmann, K. J., Cook, J. C., Joyce, J. G., Brown, D. R., Schultz, L. D., George, H. A., Rosolowsky, M., Fife, K. H., and Jansen, K. U. (1995). Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 209, 506-518.
30. Hrisomalos, T. F., Boggs, D. L., and Fife, K. H. (1990). Human papillomavirus type 6 long control region and human cellular DNA contain related sequences. J. Virol. 64, 5188-5191.
31. Huibregtse, J. M., and Scheffner, M. (1994). Mechanisms of tumor suppressor protein inactivation by the human papillomavirus E6 and E7 oncoproteins. Semin. Virol. 5, 357-367.
32. Iftner, T., Bierfelder, S., Csapo, Z., and Rister, H. (1988). Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J. Virol. 62, 3655-3661.
33. Iftner, T., Oft, M., Bohm, S., Wilczynski, S. P., and Pfister, H. (1992). Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J. Virol. 66, 4639-4646.
34. Jeon, S., and Lambert, P. F. (1995). Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92, 1654-1658.
35. Jurka, J., Kaplan, D. J., Duncan, C. H., Walichiewicz, J., Milosavljevic, A., Murali, G., and Solus, J. F. (1993). Identification and characterization of new human medium reiteration frequency repeats. Nucleic Acids Res. 21, 1273-1279.
36. Kadish, A. S., Hagan, R. J., Ritter, D. B., Goldberg, G. L., Romney, S. L., Kanetsky, P. A., Beiss, B. K., and Burk, R. D. (1992). Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. Hum. Pathol. 23, 1262-1269.
37. Kasher, M. S., and Roman, A. (1988). Characterization of human papillomavirus type 6b DNA isolated from an invasive squamous carcinoma of the vulva. Virology 165, 225-233.
38. Kitasato, H., Delius, H., zur Hausen, H., Sorger, K., Rosl, F., and de Villiers, E. M. (1994). Sequence rearrangements in the upstream regulatory region of human papillomavirus type 6: Are these involved in malignant transition? J. Gen. Virol. 75, 1157-1162.
39. Kulke, R., Gross, G. E., and Pfister, H. (1989). Duplication of enhancer sequences in human papillomavirus 6 from condylomas of the mamilla. Virology 173, 284-290.
40. Lorincz, A. T., Reid, R., Jenson, A. B., Greenberg, M. D., Lancaster, W., and Kurman, R. J. (1992). Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79, 328-337.
41. Mevorach, R. A., Cos, L. R., di Sant'Agnese, P. A., and Stoler, M. (1990). Human papillomavirus type 6 in grade I transitional cell carcinoma of the urethra. J. Urol. 143, 126-128.
42. Mounts, P., Shah, K. V., and Kashima, H. (1982). Viral etiology of juvenile-and adult-onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA 79, 5425-5429.
43. Oft, M., Bohm, S., Wilczynski, S. P., and Iftner, T. (1993). Expression of the different viral mRNAs of human papilloma virus 6 in a squamous-cell carcinoma of the bladder and the cervix. Int. J. Cancer 53, 924-931.
44. Okagaki, T., Clark, B. A., Zachow, K. R., Twiggs, L. B., Ostrow, R. S., Pass, F., and Faras, A. J. (1984). Presence of human papillomavirus in verrucous carcinoma (Ackerman) of the vagina: Immunocytochemical, ultrastructural, and DNA hybridization studies. Arch. Pathol. Lab. Med. 108, 567-570.
45. Pim, D., Storey, A., Thomas, M., Massimi, P., and Banks, L. (1994). Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 9, 1869-1876.
46. Purdie, K. J., Sexton, C. J., Proby, C. M., Glover, M. T., Williams, A. T., Stables, J. N., and Leigh, I. M. (1993). Malignant transformation of cutaneous lesions in renal allograft patients: A role for human papillomavirus. Cancer Res. 53, 5328-5333.
47. Rando, R. F., Groff, D. E., Chirikjian, J. G., and Lancaster, W. D. (1986a). Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J. Virol. 57, 353-356.
48. Rando, R. F., Lancaster, W. D., Han, P., and Lopez, C. (1986b). The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements. Virology 155, 545-556.
49. Roman, A., and Brown, D. (1995). Sequence variation in the extreme 5′ end of the human papillomavirus type 6a long control region. J. Infect. Dis. 171, 697-700.
50. Romanczuk, H., Thierry, F., and Howley, P. M. (1990). Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64, 2849-2859.
51. Roth, E. J., Kurz, B., Liang, L., Hansen, C. L., Dameron, C. T., Winge, D. R., and Smotkin, D. (1992). Metal thiolate coordination in the E7 proteins of human papilloma virus 16 and cottontail rabbit papilloma virus as expressed in Escherichia coli. J. Biol. Chem. 267, 16390-16395.
52. Rübben, A., Beaudenon, S., Favre, M., Schmitz, W., Spelten, B., and Grussendorf-Conen, E. I. (1992). Rearrangements of the upstream regulatory region of human papillomavirus type 6 can be found in both Buschke-Lowenstein tumors and condylomata acuminata. J. Gen. Virol. 73, 3147-3153.
53. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning. A Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory, New York.
54. Sang, B. C., and Barbosa, M. S. (1992). Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. Proc. Natl. Acad. Sci. USA 89, 8063-8067.
55. Scheffner, M., Romanczuk, H., Munger, K., Huibregtse, J. M., Mietz, J. A., and Howley, P. M. (1994). "Human Pathogenic Papillomaviruses" (H. zur Hausen, Ed.), pp. 83-99. Springer-Verlag, Berlin.
56. Schmitt, A., Harry, J. B., Rapp, B., Wettstein, F. O., and Iftner, T. (1994). Comparison of the properties of the E6 and E7 genes of low-and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J. Virol. 68, 7051-7059.
57. Schwarz, E., Durst, M., Demankowski, C., Lattermann, O., Zech, R., Wolfsperger, E., Suhai, S., and zur Hausen, H. (1983). DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J. 2, 2341-2348.
58. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., and zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
59. Sedman, S. A., Hubbert, N. L., Vass, W. C., Lowy, D. R., and Schiller, J. T. (1992). Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity. J. Virol. 66, 4201-4208.
60. Seite, P., Hillion, J., Leroux, D., Berger, R., and Larsen, C. J. (1993). Common sequence in chromosome translocations affecting B- and T-cell malignancies: A novel recombination site? Genes Chromosomes Cancer 6, 253-254. [Letter]
61. Smotkin, D., Prokoph, H., and Wettstein, F. O. (1989). Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63, 1441-1447.
62. Steinberg, B. M. (1987). "The Papovaviridae" (N. P. Salzman and P. M. Howley, Eds.), pp. 265-292. Plenum, New York.
63. Swift, F. V., Bhat, K., Younghusband, H. B., and Hamada, H. (1987). Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome. EMBO J. 6, 1339-1344.
64. Thierry, F., and Yaniv, M. (1987). The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 6, 3391-3397.
65. Tommasino, M., and Crawford, L. (1995). Human papillomavirus E6 and E7: Proteins which deregulate the cell cycle. BioEssays 17, 509-518.
66. Turek, L. P. (1994). The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv. Virus Res. 44, 305-356.
67. Vousden, K. H. (1995). Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol. 6, 109-116.
68. Wahls, W. P., and Moore, P. D. (1990). Homologous recombination enhancement conferred by the Z-DNA motif d(TG)30 is abrogated by simian virus 40 T antigen binding to adjacent DNA sequences. Mol. Cell Biol. 10, 794-800.
69. Wilczynski, S. P., Oft, M., Cook, N., Liao, S. Y., and Iftner, T (1993). Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix. Hum. Pathol. 24, 96-102.
70. Wu, T. C., and Mounts, P. (1988). Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6. J. Virol. 62, 4722-4729.
71. Yee, C., Krishnan Hewlett, I., Baker, C. C., Schlegel, R., and Howley, P. M. (1985). Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119, 361-366.
72. zur Hausen, H. (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.
73. zur Hausen, H., Ed. (1994). "Human Pathogenic Papillomaviruses," pp. 131-156. Springer-Verlag, Berlin.